Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Autor: Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E., Rathnam, Krishnakumar *, Khattry, Navin *, Punatar, Sachin *, Apperley, Jane F., Charbonnier, Aude *, Deininger, Michael, de Lavallade, Hugues *, Granacher, Nikki *, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro *, Mauro, Michael, Vandenberghe, Peter, Verhoef, Gregor *, Whiteley, Andrew R., Nag, Arijit *, Apte, Shashikant, Yao, Siu-Long, Inamdar, Sandeep *, Dillu, Ruchika Irene *, Sreenivasan, Jayasree *, Chimote, Geetanjali *
Zdroj: In Blood 15 November 2022 140 Supplement 1:205-207
Databáze: ScienceDirect